$TMEF
Tipmefast, Inc.

2023 Q2 Form 10-Q Financial Statement

#000155889123000039 Filed on April 26, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $3.800K $3.250K $2.300K
YoY Change -28.97% 41.3%
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00 $0.00
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$3.800K -$3.250K -$2.300K
YoY Change -28.97% 41.3% -68.06%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00 $0.00
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 5.600M shares 5.600M shares 5.600M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $0.00 $0.00 $0.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $0.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $0.00
Total Long-Term Assets $0.00
Total Assets $0.00
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $12.32K
YoY Change 185.19%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $24.77K
YoY Change 138.86%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $24.77K
Total Long-Term Liabilities
Total Liabilities $24.77K
YoY Change 138.86%
SHAREHOLDERS EQUITY
Retained Earnings -$110.8K
YoY Change 14.94%
Common Stock $5.600K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$24.77K
YoY Change
Total Liabilities & Shareholders Equity $0.00
YoY Change

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$3.800K -$3.250K -$2.300K
YoY Change -28.97% 41.3% -68.06%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$4.150K -$8.080K
YoY Change -48.64%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $4.150K $0.00
YoY Change
NET CHANGE
Cash From Operating Activities -$4.150K -$8.080K
Cash From Investing Activities $0.00
Cash From Financing Activities $4.150K $0.00
Net Change In Cash $0.00 -$8.080K
YoY Change -100.0%
FREE CASH FLOW
Cash From Operating Activities -$4.150K -$8.080K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
333-222880
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
TIPMEFAST, INC
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
83-4057513
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
Raid Chalil
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
HaShnura St 1
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
ZihronYa’akow
CY2023Q1 dei Entity Address Country
EntityAddressCountry
IL
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
30950
CY2023Q1 dei City Area Code
CityAreaCode
972
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
373-70057
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
true
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5600000 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5600000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5600000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5600000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5600000 shares
CY2023Q1 us-gaap Revenues
Revenues
0 usd
CY2022Q1 us-gaap Revenues
Revenues
0 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2000 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
1250 usd
CY2022Q1 us-gaap Professional Fees
ProfessionalFees
300 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
3250 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
2300 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
0 usd
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
0 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-3250 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-2300 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5600000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5600000 shares
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2720 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-2300 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-5020 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-17720 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-3250 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-20970 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-3250 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-2300 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2900 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-7780 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2000 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4150 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8080 usd
CY2023Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
4150 usd
CY2022Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4150 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
0 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8080 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8080 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
0 usd
CY2022Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
0 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font:10pt Times New Roman;margin:0"><span style="border-bottom:1px solid #000000">Use of Estimates</span></p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5600000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5600000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5600000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5600000 shares

Files In Submission

Name View Source Status
0001558891-23-000039-index-headers.html Edgar Link pending
0001558891-23-000039-index.html Edgar Link pending
0001558891-23-000039.txt Edgar Link pending
0001558891-23-000039-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tpmf-20230331.htm Edgar Link pending
tpmf-20230331.xsd Edgar Link pending
tpmf_ex31z1.htm Edgar Link pending
tpmf_ex31z2.htm Edgar Link pending
tpmf_ex32z1.htm Edgar Link pending
tpmf_ex32z2.htm Edgar Link pending
tpmf-20230331_def.xml Edgar Link unprocessable
tpmf-20230331_lab.xml Edgar Link unprocessable
tpmf-20230331_pre.xml Edgar Link unprocessable
tpmf-20230331_htm.xml Edgar Link completed
tpmf-20230331_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable